HOME >> MEDICINE >> NEWS
Drug/intervention combinations offer benefit in severe CVD

rdiac death, heart attack, transplantation or re-hospitalization for cardiac reasons.

The study found that patients with poor LV function who received FDG PET imaging yielded fewer cardiac events over the course of a year compared with patients who received standard care (HR=0.81) but this did not reach statistical significance. However, among those patients who had not recently had an angiography X-ray exam, the PET-guided therapy significantly reduced cardiac death rates compared to those who received standard care (HR=0.4).

"Overall the study was too small to detect a significant benefit with PET imaging. With subsequent analysis, our results suggest that physician decisions about therapies for left ventricular dysfunction could be more accurate and effective with the use of imaging technologies like PET-guided therapy, particularly to manage disease in patients without a recent angiography," said Robert Beanlands, M.D., of the University of Ottawa Heart Institute, and lead author of the study. "Long-term follow up will determine whether or not these benefits are sustained and cost effective."

Dr. Beanlands will present his study on Monday, March 26, at 4:45 p.m. in Hall A.


A Phase III International Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition with Tilarginine Acetate Injection in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction (Presentation Number: 412-8)

Cardiogenic shock (CS) is one of the most common causes of death among hospitalized patients with acute myocardial infarction (AMI). The TRIUMPH Study tested whether nitric oxide synthase (NOS) inhibition with Tilarginine Acetate (TAI) would reduce mortality with refractory CS, despite an open infarct-related artery. The TRIUMPH study will be simultaneously published in the Journal of the American Medical Association (JAMA) and will appear in the March 28 print issue.


'"/>

Contact: Leslie Humbel
lhumbel@spectrumscience.com
504-613-2418
American College of Cardiology
26-Mar-2007


Page: 1 2 3 4 5

Related medicine news :

1. Novel therapy combinations gain ground in treating hepatitis
2. Drug combinations improve survival for patients with heart disease
3. Hormone therapy offers new hope for ovarian cancer patients
4. TB test offers patients quicker and easier diagnosis
5. Panel offers guidelines on skin reactions to new class of cancer drugs
6. Supersize me mice research offers grim warning for Americas fast food consumers
7. Developments in tissue engineering offer new sources for stem cell treatments
8. Targeted nanoparticles incorporating siRNA offer promise for cancer treatment
9. New treatment offers relief from chronic back pain
10. Commonly used drug offers promise for premature babies
11. Vitamin D supplements may offer cheap and effective immune system boost against TB

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2020)... ... May 27, 2020 , ... Productive Plastics, a ... face shields to be used as personal protective equipment (PPE) to ... are single use, made to be worn by frontline healthcare professionals and for ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... can impact the brain causing post infectious encephalitis. The work was conducted ... and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) could adversely attack the central nervous ...
(Date:5/26/2020)... ... 26, 2020 , ... As much of the country continues ... are joining forces to start a country-wide movement of physical activity to honor ... #FitForTheFrontLine is a national fitness challenge beginning Tuesday, May 26 and culminating on ...
(Date:5/21/2020)... ... May 21, 2020 , ... Summit Medical , an ... over one million FDA-compliant face shields — designed, engineered and manufactured in the ... need for personal protective equipment (PPE) for both front-line health care workers and ...
(Date:5/21/2020)... ... 2020 , ... Friends of Lisa Campbell, announce that Lisa Campbell, candidate for ... Southeast Advocates (PPSEA). PPSEA educates and lobbies on behalf of women’s health ... reproductive health care. PPSEA educates and lobbies on behalf of women’s health and works ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... RATON, Fla. (PRWEB) , ... May 21, 2020 ... ... is opening their offices beginning May 11th. The offices had been closed due ... of non-essential businesses, particularly in the dental field. The office has remained open ...
(Date:5/21/2020)... ... ... Murrieta Genomics has partnered with Life Science Nation (LSN) ... a special discount rate to the Digital RESI 3-Day Global Conference being held June ... bring together startups with early-stage investors and strategic channel partners. The goal was to ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... Labyrinthe Labs ... support formula called Lefa . A soothing cream designed for fast-action relief of ... whole plant phytocannabinoids proven to soothe and support tired joints and muscles. , ...
Breaking Medicine Technology:
Cached News: